Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas Rafael B. ErlichDanny RickwoodAlexander Guminski Original Article 09 April 2008 Pages: 381 - 389
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients Erica L. WoodahlJoanne WangJeannine S. McCune Original Article 09 April 2008 Pages: 391 - 401
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study Jaime FeliuJose Luis FirvidaFor the Oncopaz Cooperative Group Original Article 09 April 2008 Pages: 403 - 409
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine Maryse LemaireLouise F. MomparlerRichard L. Momparler Original Article 09 April 2008 Pages: 411 - 416
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy Ahmad AwadaMartine J. PiccartHoward A. Burris III Original Article 29 April 2008 Pages: 417 - 425
Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer Hyo Jin LeeDo Yeun ChoSamyong Kim Original Article 16 April 2008 Pages: 427 - 432
Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis Hee Yeon SeoDae Sik KimJun Suk Kim Original Article 09 April 2008 Pages: 433 - 439
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine Smitha S. KrishnamurthiJoanna M. BrellScot C. Remick Original Article 15 April 2008 Pages: 441 - 450
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies Paula M. FracassoJoel PicusRobert E. Bellet Original Article 15 April 2008 Pages: 451 - 458
Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma Ju Hyun ShimJoong-Won ParkChang-Min Kim Original Article 25 April 2008 Pages: 459 - 467
A Bayesian population PK–PD model for ispinesib/docetaxel combination-induced myelosuppression Steven J. KathmanDaphne H. WilliamsMohammed Dar Original Article 29 April 2008 Pages: 469 - 476
A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state C. L. O’BryantC. H. LieuS. G. Eckhardt Original Article 29 May 2008 Pages: 477 - 489
ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite O. HemmingssonY. ZhangP. Naredi Original Article 14 May 2008 Pages: 491 - 499
Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients Koji OkabayashiHirotoshi HasegawaYuko Kitagawa Original Article 07 May 2008 Pages: 501 - 507
Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age Dae Young ZangDae Hyun YangBong Hwa Lee Original Article 15 May 2008 Pages: 509 - 516
Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma Islam R. YounisSamuel MaloneWilliam P. Petros Original Article 22 May 2008 Pages: 517 - 524
Effect of antacid on imatinib absorption Brian A. SparanoMerrill J. EgorinJan H. Beumer Original Article 24 May 2008 Pages: 525 - 528
Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer Yoon Jae KimSeungmin BangSi Young Song Original Article 03 September 2008 Pages: 529 - 533
Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer Hee Man KimSeungmin BangSeung Woo Park Original Article 01 October 2008 Pages: 535 - 541
Carbamazepine induces bioactivation of cyclophosphamide and thiotepa Corine EkhartSjoerd RodenhuisAlwin D. R. Huitema Short Communication Open access 24 April 2008 Pages: 543 - 547
Pathologic complete response after palliative 3rd line chemotherapy with capecitabine alone in metastatic colorectal cancer Hyeon Jin ChoSu-Jung KimEun Kyung Hong Short Communication 07 May 2008 Pages: 549 - 553
Detection of complete response to imatinib mesylate (Glivec®/Gleevec®) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma Mehmet Emin KalenderAlper SevincCelalettin Camci Short Communication 08 July 2008 Pages: 555 - 559
Detection of complete response to imatinib mesylate (Glivec®/Gleevec®) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma Mehmet Emin KalenderAlper SevincCelalettin Camci Erratum 20 August 2008 Pages: 561 - 561
Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias Elena MarangonMarco CitterioMassimo Zucchetti Letter to the Editor 03 June 2008 Pages: 563 - 566
MDA-MB-435 cells are from melanoma, not from breast cancer Marc Lacroix Letter to the Editor 24 May 2008 Pages: 567 - 567
Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand Henriette GourdeauJames B. McAlpinePierre Falardeau Erratum 22 October 2008 Pages: 569 - 569
